IANNONE, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 4.634
AS - Asia 1.591
EU - Europa 1.234
SA - Sud America 374
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 7.904
Nazione #
US - Stati Uniti d'America 4.564
SG - Singapore 600
IT - Italia 369
CN - Cina 361
BR - Brasile 289
SE - Svezia 222
RU - Federazione Russa 211
HK - Hong Kong 185
VN - Vietnam 138
DE - Germania 126
GB - Regno Unito 74
FR - Francia 68
IN - India 58
BD - Bangladesh 51
FI - Finlandia 46
ID - Indonesia 35
CA - Canada 33
BE - Belgio 32
IQ - Iraq 25
AR - Argentina 23
TR - Turchia 21
MX - Messico 19
PL - Polonia 19
PK - Pakistan 18
CO - Colombia 16
CI - Costa d'Avorio 14
EC - Ecuador 14
JP - Giappone 14
UZ - Uzbekistan 14
ZA - Sudafrica 14
ES - Italia 13
NL - Olanda 10
SA - Arabia Saudita 10
CL - Cile 9
MA - Marocco 9
PH - Filippine 9
UA - Ucraina 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
MY - Malesia 8
KE - Kenya 7
TN - Tunisia 7
AT - Austria 6
IE - Irlanda 6
PY - Paraguay 6
AZ - Azerbaigian 5
DZ - Algeria 5
EG - Egitto 5
IL - Israele 4
KZ - Kazakistan 4
PE - Perù 4
RO - Romania 4
AU - Australia 3
BO - Bolivia 3
EU - Europa 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
JO - Giordania 3
LB - Libano 3
AL - Albania 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
KG - Kirghizistan 2
LV - Lettonia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
QA - Qatar 2
TH - Thailandia 2
TW - Taiwan 2
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HU - Ungheria 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LR - Liberia 1
MD - Moldavia 1
MK - Macedonia 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TT - Trinidad e Tobago 1
VG - Isole Vergini Britanniche 1
Totale 7.904
Città #
Fairfield 558
Ashburn 497
Woodbridge 397
Singapore 340
Chandler 285
Houston 240
Seattle 211
Ann Arbor 193
Cambridge 185
Hong Kong 183
Wilmington 183
Nyköping 182
San Jose 181
Beijing 138
Dallas 134
Milan 133
New York 117
Los Angeles 68
Council Bluffs 55
Nanjing 51
Rome 49
Roxbury 47
Lawrence 46
Bari 41
Lauterbourg 38
Inglewood 35
Santa Clara 35
Brussels 32
Munich 32
Ho Chi Minh City 29
Des Moines 27
Brooklyn 26
Hanoi 26
Jacksonville 26
São Paulo 26
Dearborn 25
Columbus 23
Jakarta 23
Dong Ket 22
Helsinki 22
Frankfurt am Main 19
Princeton 19
Warsaw 17
The Dalles 16
Atlanta 15
San Diego 15
Abidjan 14
Buffalo 14
Boardman 13
Denver 13
Montreal 13
Boston 12
Orem 12
Pune 12
Rio de Janeiro 12
Tokyo 12
London 11
Tashkent 11
Chicago 10
Nanchang 10
Phoenix 10
Turin 10
Belo Horizonte 9
Haiphong 9
Hebei 9
Johannesburg 9
Medellín 9
San Francisco 9
Dhaka 8
Falkenstein 8
Mexico City 8
Moscow 8
Shanghai 8
Shenyang 8
Chennai 7
Curitiba 7
Figino 7
Paris 7
Toronto 7
Bologna 6
Guangzhou 6
Ha Long 6
Istanbul 6
Jiaxing 6
Kunming 6
Lahore 6
Maringá 6
Mumbai 6
Stockholm 6
Tianjin 6
Zhengzhou 6
Baghdad 5
Baku 5
Brasília 5
Casablanca 5
Da Nang 5
Dublin 5
Florence 5
Fortaleza 5
Hangzhou 5
Totale 5.505
Nome #
Mesalazine for people with diverticular disease: A systematic review of randomized controlled trials 302
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm 262
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 216
Obesity as predictor of postoperative outcomes in liver transplant candidates: Review of the literature and future perspectives 214
Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population 210
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors 206
Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy 204
Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model 196
Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? 196
Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials 191
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis? 188
Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement 166
Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease 165
The helper lymphocyte and mast cell immunohistochemical pattern in nonceliac gluten sensitivity 155
Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis 154
Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease 153
Inter-observer agreement of a new endoscopic score for ulcerative colitis activity: Preliminary experience 142
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 141
Liver stiffness and portal blood flow modifications induced by a liquid meal consumption: Pathogenetic mechanisms and clinical relevance 134
Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study 133
Helicobacter pylori primary and secondary genotypic resistance to clarithromycin and levofloxacin detection in stools: A 4-year scenario in Southern Italy 131
Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study 127
Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: What needs to be explored? 125
Acute pancreatitis in elderly patients: A retrospective evaluation at hospital admission 122
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 121
Escherichia coli Nissle 1917 in ulcerative colitis treatment: Systematic review and meta-analysis 111
Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model 111
Assessment of body composition: Intrinsic methodological limitations and statistical pitfalls 106
New fecal test for non-invasive Helicobacter pylori detection: A diagnostic accuracy study 102
Role of concomitant therapy for Helicobacter pylori eradication: A technical note 101
null 100
Concomitant and Bismuth Quadruple Therapy for Helicobacter pylori Eradication in Southern Italy: Preliminary Data from a Randomized Clinical Trial 99
The spectrum of small intestinal lesions in patients with unexplained iron deficiency anemia detected by video capsule endoscopy 97
Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis C 94
null 90
HCV-positive kidney transplant patients treated with direct-acting antivirals maintain stable medium-term graft function despite persistent reduction in tacrolimus trough levels 90
Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis 89
A prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection: A further confirmation of geographic Weight 87
Noninvasive molecular analysis of Helicobacter pylori: is it time for tailored first-line therapy? 86
null 86
null 86
Biological markers for non-celiac gluten sensitivity: A question awaiting for a convincing answer 85
Familial adenomatous polyposis small bowel surveillance: could indicators for video-capsule endoscopy be ascertained? 83
Epstein-Barr Virus-Related hyperacute hepatitis: May intravenous Ster-Oids be an effective approach? 83
null 82
null 81
null 81
Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta-analysis of randomized controlled trials 80
null 80
Familial intestinal polyposis and device assisted enteroscopy: where do we stand? 79
null 79
null 79
Impact of Bifidobacterium longum Subspecies infantis on Pediatric Gut Health and Nutrition: Current Evidence and Future Directions 76
Helicobacter pylori Secondary Antibiotic Resistance after One or More Eradication Failure: A Genotypic Stool Analysis Study 75
null 74
Sequential therapy for helicobacter pylori in elderly patients: Effectiveness, safety and predictors of success 74
Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association 74
Natural History and Hepatitis B Virus Surface Antigen (HBsAg) Spontaneous Seroclearance in Hepatitis B Virus e-Antigen (HBeAg)-Negative Patients with Inactive Chronic Infection: A Multicenter Regional Study from South Italy 72
Effect of Visual Booklets to Improve Bowel Preparation in Colonoscopy: Systematic Review with Meta-Analysis 72
null 72
null 69
null 67
Epithelial turnover in duodenal familial adenomatous polyposis: A possible role for estrogen receptors? 67
null 66
Transmission electron microscopy helpfulness in Whipple's disease masked by immunosuppressant therapy for arthritis 66
null 59
null 59
The Interaction Between Celiac Disease and Intestinal Microbiota 56
Novel frontiers of agents for bowel cleansing for colonoscopy 55
Letter: Could sequential therapy extended to 14 days replace prolonged triple regimens for Helicobacter pylori treatment? 54
Helicobacter pylori, liver cirrhosis, and portal hypertension: an updated appraisal 44
null 42
null 39
null 36
Seronegative Celiac Disease and immunoglobulin deficiency: Where to look in the submerged iceberg? 34
Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: how should rifabutin be managed in rescue regimens? 32
null 13
Pancreatic Cystic Lesions and Endoscopic Ultrasound Diagnostic Equipment: A Literature Review 5
Totale 8.233
Categoria #
all - tutte 31.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.540


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022427 52 8 15 19 19 37 15 27 27 38 66 104
2022/2023695 87 115 59 57 56 104 9 84 90 4 16 14
2023/2024265 16 41 9 27 17 106 7 5 2 15 5 15
2024/20251.072 22 19 58 25 40 97 174 114 39 70 142 272
2025/20262.705 393 134 242 207 334 112 233 70 370 261 91 258
2026/2027306 306 0 0 0 0 0 0 0 0 0 0 0
Totale 8.233